Shot:  

• The companies expand their strategic partnership to commercialize six new biosimilar product candidates for the Asian markets
• In Mar’2020- the companies collaborated for AVT02 (biosimilar- adalimumab). The collaboration targets Taiwan- Korea- Hong Kong- Philippines- Vietnam- Thailand- Cambodia- Myanmar- Malaysia- Singapore- Indonesia- India- Bangladesh- and Pakistan
• The expansion deepens the partnership b/w the two companies to accelerate the introduction of a high-quality biosimilar to patients in Asia

­ Ref: Alvotech | Image: Alvotech